Spectral AI ( (MDAI) ) just unveiled an update.
On March 21, 2025, Spectral AI, Inc. completed a securities purchase agreement and a debt financing transaction, raising a total of $2.7 million from equity financing and securing up to $15 million in debt financing from Avenue Venture Opportunities Fund II, L.P. The funds will support the commercialization of its DeepView System in the U.S. market. The financing includes an initial draw of $8.5 million and potential additional debt contingent upon FDA clearance and further equity raise. This financial boost is expected to accelerate Spectral AI’s market entry and enhance its operational capabilities, positioning the company for growth and innovation in the medical diagnostics industry.
More about Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company specializing in medical diagnostics to enhance treatment decisions in wound care, particularly for burn patients. The company aims to transform wound care management with its DeepView® System, which uses AI algorithms to provide immediate assessments of burn wounds’ healing potential, thereby improving patient outcomes and reducing healthcare costs.
YTD Price Performance: -48.35%
Average Trading Volume: 898,609
Technical Sentiment Signal: Strong Buy
Current Market Cap: $34.64M
See more data about MDAI stock on TipRanks’ Stock Analysis page.